This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Apr 20;152(8):JC4-10.

doi: 10.7326/0003-4819-152-8-201004200-02010.

Review: current evidence shows no overall benefit of aspirin for primary prevention of cardiovascular disease in diabetes

Michael LeFevre¹

Affiliations

PMID: 20404367
DOI: 10.7326/0003-4819-152-8-201004200-02010

Comment

Review: current evidence shows no overall benefit of aspirin for primary prevention of cardiovascular disease in diabetes

Michael LeFevre. Ann Intern Med. 2010.

. 2010 Apr 20;152(8):JC4-10.

doi: 10.7326/0003-4819-152-8-201004200-02010.

Author

Michael LeFevre¹

Affiliation

¹ University of Missouri, Columbia, Missouri, USA.

PMID: 20404367
DOI: 10.7326/0003-4819-152-8-201004200-02010

No abstract available

PubMed Disclaimer

Comment on

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.
De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, Nicolucci A. De Berardis G, et al. BMJ. 2009 Nov 6;339:b4531. doi: 10.1136/bmj.b4531. BMJ. 2009. PMID: 19897665 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon